MicroConstants China in-licensed global rights to novel discovered-in-China AA98 antibodies for cancer and other diseases from Beijing's Institute of Biophysics in a $16 million deal; China Traditional Chinese Medicine Co. will pay as much as $1.3 billion for an 82% stake in fellow TCM maker Jiangyin Tianjiang Pharma; 3SBio of Shenyang acquired Sirton Pharmaceuticals SpA, a Northern Italy CMO/CRO with a focus on injected drugs; Fosun Pharma signed a framework agreement to build a hospital with First Hospital of Qiqihar City; Waters Corporation, a US lab equipment maker, and the Chinese Pharmacopeia Commission officially opened the Joint Open Laboratory in Beijing to set TCM standards; Novotech, an Australian CRO, announced an enlarged, permanent office in Hong Kong to run clinical trials; and Menarini Asia-Pacific received China approval to market Kerasal Nail™, an OTC fungal nail product made by Moberg Pharma AB of Sweden.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
